US drugmakers fall after Trump's new tariff warnings
Shares of some U.S. drugmakers fall, amid a broader market sell-off, after President Donald Trump threatened steep tariffs on the sector
Pharma stocks briefly rose on Wednesday after Trump spared pharmaceutical products from reciprocal tariffs
*Trump said tariffs on the sector are expected to be announced in the near future, and are under review right now
Shares of Merck MRK.N down 1.8%, Biogen BIIB.O down 2%, Pfizer PFE.N down 2.5%, Eli Lilly LLY.N down 4.5% and AbbVie ABBV.N down 2.3%; Arca Pharmaceutical Index .DRG down 3%
Up to last close, LLY up 2.2% , MRK down 13.2%, BIIB down 14.5% and PFE down 8.4% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

Meta Stock Price Forecast 2026-2030: Can META Hit $1,000?

Tradingkey






